Paclitaxel
پاکلیتاکسل
🎗️ Antineoplastic And Immunomodulating AgentsTaxane
Market / country: 🇺🇸 USA
Taxol (US)
🧮 Dose calculator
Ovarian cancer · Regimen source: FDA Paclitaxel · Dosage and Administration
- • Or 135 mg/m² over 24 h. Premedicate: dexamethasone 20 mg PO 12 and 6 h before, diphenhydramine 50 mg and cimetidine 300 mg IV 30–60 min before. Non-PVC sets. FDA Paclitaxel · Dosage and Administration
- • Only under an oncologist in an equipped centre. Calculator = label mg/m² × BSA (Mosteller); protocol, cycle interval and adjustment for CBC and renal/hepatic function rest with the oncology team. FDA Paclitaxel · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ History of hypersensitivity to paclitaxel or polyoxyl 35 castor oil drugs; baseline neutrophils <1,500 (solid tumours) or <1,000 (Kaposi sarcoma). FDA Paclitaxel · Contraindications
Warnings
- • Boxed warning: anaphylaxis and severe hypersensitivity (fatal despite premedication); myelosuppression — not with neutrophils <1,500. FDA Paclitaxel · Warnings
Formulations
- 6 mg/mL (30/100/150/300 mg) — injection 🇺🇸 USA FDA Paclitaxel · How Supplied
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Paclitaxel · Pregnancy
“Paclitaxel injection can cause fetal harm when administered to a pregnant woman.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Paclitaxel · Nursing Mothers
“Following intravenous administration of carbon 14 labeled paclitaxel to rats on days 9 to 10 postpartum, concentrations of radioactivity in milk were higher than in plasma and declined in parallel with the plasma concentrations.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Paclitaxel · Pediatric Use
“The safety and effectiveness of paclitaxel injection in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Paclitaxel · Geriatric Use
“Of 2228 patients who received paclitaxel in 8 clinical studies evaluating its safety and effectiveness in the treatment of advanced ovarian cancer, breast carcinoma, or NSCLC, and 1570 patients who were randomized to receive paclitaxel in the adjuvant breast cancer study, 649 patients (17%) were 65 years or older and …”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA075184
- DailyMed (FDA label)FDA Paclitaxel
- MedlinePlus (NIH)Paclitaxel (with albumin) InjectionPaclitaxel (with polyoxyethylated castor oil) Injection
- WHO ATC/DDDL01CD01
- Darooyab (Iran)Paclitaxel
🇮🇷 Registered in Iran Darooyab · G-1044/Paclitaxel
Dosage forms with Iranian generic codes, per Darooyab.
- 13879 · PACLITAXEL 100MG INJ · فرآورده تزریقی پاکلیتاکسل ۱۰۰ میلیگرم
- 02395 · PACLITAXEL 150MG/25ML VIAL · ویال پاکلیتاکسل ۱۵۰ میلیگرم / ۲۵ میلیلیتر
- 04098 · PACLITAXEL 300MG/50ML VIAL · ویال پاکلیتاکسل ۳۰۰ میلیگرم / ۵۰ میلیلیتر
- 00943 · PACLITAXEL 30MG/5ML VIAL · ویال پاکلیتاکسل ۳۰ میلیگرم / ۵ میلیلیتر
- 02674 · PACLITAXEL 50MG/25MG VIAL · ویال پاکلیتاکسل ۵۰ میلیگرم / ۲۵ میلیگرم
- 02396 · PACLITAXEL 6MG/ML 16.7ML VIAL · ویال پاکلیتاکسل ۶ میلیگرم / میلیلیتر ۱۶٫۷ میلیلیتر
- 15260 · PACLITAXEL ALBUMIN BOUND 100MG VIAL · ویال پاکلیتاکسل آلبومین بووند ۱۰۰ میلیگرم
- 50293 · PACLITAXEL INJECTION PARENTERAL 6 mg/1mL 50 mL · فرآورده تزریقی پاکلیتاکسل ۶ میلیگرم / ۱ میلیلیتر ۵۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Paclitaxel · How SuppliedFDA Paclitaxel · Dosage and AdministrationFDA Paclitaxel · ContraindicationsFDA Paclitaxel · WarningsFDA Paclitaxel · SPL approval / marketing categoryFDA Paclitaxel · PregnancyFDA Paclitaxel · Nursing MothersFDA Paclitaxel · Pediatric UseFDA Paclitaxel · Geriatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1044/Paclitaxel
- Clinical review⚠ Unverified